3555 results for «231»
3555 results
SELUTION DeNovo study: powered to change medical practice
18 May 2021 – From EuroPCR 2021
Watch this session presented by Christian Spaulding in order to gain insight into how the SELUTION DeNovo study could change medical practice, to understand the strategy and what differentiates the SELUTION DeNovo study, and to learn about the study design and key milestones.

The future and vision of intravascular imaging
18 May 2021 – From EuroPCR 2021
Watch this session presented by Nieves Gonzalo in order to highlight the benefits and future of intravascular imaging, to share the benefits of using a structured and streamlined workflow, MLD-MAX, and to understand the benefits of using AI during the crucial steps of PCI.

Leading dose solutions for your interventions
18 May 2021 – From EuroPCR 2021
Watch this session presented by Laurent Fieldman in order to understand how innovations can help you optimising dose in your procedures, to learn about latest dose reduction tools for complex interventions, and to review expert perspective on using innovative dose reduction tools.

Next-Generation Structural Heart Pipeline
18 May 2021 – From EuroPCR 2021
Watch this session presented by Jeffrey Popma and Eberhard Grube to learn more about next-generation Structural Heart Pipeline.

The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in native and small annuli
18 May 2021 – From EuroPCR 2021
Watch this session presented by Raul Moreno and Dave Smith in order to learn about the hemodynamic performance of the ALLEGRA TAVI system, to share the experience of European centres through challenging ALLEGRA cases, and to focus on the outcome of the ALLEGRA TAVI system in small annuli...

Complex PCI with short DAPT: the trade-off between ischaemia and bleeding
18 May 2021 – From EuroPCR 2021
Watch this session presented by Benjamin Faurie, Roxana Mehran and Manel Sabate in order to understand the trade-off between ischaemic risk and bleeding risk, to hear about the results of LM-PCI with Biofreedom Ultra and short DAPT, and to learn how to use short DAPT in patients undergoing complex...

Short DAPT in high bleeding risk: ready for prime time?
20 May 2021 – From EuroPCR 2021
Watch this session presented by Roxana Mehran, Davide Capodanno, Pieter Smits and Marco Valgimigli in order to discuss integrated framework for the decision making on DAPT duration in high bleeding risk patients, to understand the implications of the available evidence and gaps in knowledge, and to learn...

Unusual situations during TAVI
21 Nov 2021 – From PCR London Valves 2021
Watch this PCR London Valves 2021 session to benefit from the experience of our speakers and discover, among others, ECMO assistance during TAVI in high-risk patient with recent COVID-19 pneumonia, bailout "balloon trapping technic" to facilitate crossing the aortic valve during TAVI, or how to manage residual...

PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI
21 Nov 2021 – From PCR London Valves
Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.

Transcatheter mitral valve replacement: patient selection and hemodynamic stability
22 Nov 2021 – From PCR London Valves
Watch this session broadcast at PCR London Valves 2021 to find out more about TMVR as a novel treatment option for patients with mitral disease, to learn how to identify the right candidate for TMVR, and to understand how to best medically manage patients peri-procedurally.

Obtaining commissural alignment in TAVI
23 Nov 2021 – From PCR London Valves 2021
Watch this session from PCR London Valves 2021 about the importance of commissural alignment in TAVI to know how to achieve commissural alignment with different TAVI systems, and to discover a step-by-step demonstration of patient-specific commissural alignment with the ACURATE neo2 THV system.

Lifetime management of patients with severe aortic stenosis
22 Nov 2021 – From PCR London Valves
Don't miss this PCR London Valves 2021 session if you wish to discuss the importance of lifetime management in patients with severe aortic stenosis, to learn about the latest CoreLab adjudicated outcomes from the Early neo2 registry, and to understand how valve design, implant technique, embolic...

Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform
23 Nov 2021 – From PCR London Valves
Explore the clinical impact of the Edwards portfolio of transcatheter devices for mitral regurgitation treatment in this PCR London Valves 2021 session that you shouldn't miss if you want to attend case-based discussions that will analyze key PASCAL features to treat mitral regurgitation and to participate...

Predictability at release means better MR outcomes; PASCAL platform significance in a matched analysis
21 Nov 2021 – From PCR London Valves 2021
Join Peter Lüdike and Philipp Lurz to learn more about about the latest study regarding the predictability of mitral regurgitation reduction using the PASCAL device.

EAPCI: patient initiatives around the world
22 Nov 2021 – From PCR London Valves 2021
In this session, you can find out more about the EAPCI Valve for Life initiative and what progress has been made in selected countries, as well as other collaborative initiatives across the world.

From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options
21 Nov 2021 – From PCR London Valves 2021
Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned. Bernard Prendergast, Philipp Lurz, Fabien Praz and Maurizio Taramasso discuss the challenges and needs regarding mitral and tricuspid valve disease treatment. They also consider what is needed to...

From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options - Part 1 - Best long-term outcomes start with the first procedure
21 Nov 2021 – From PCR London Valves
In this session from PCR London Valve 2021 dedicated to TAVI, mitral, and tricuspid, let's examine the issues related to the lifetime patient journey faced by many patients, starting with an analysis of severe aortic stenosis: how to identify the most important factors when considering the...

From TAVI to mitral and tricupid - Applying evidence to expand patients' treatment options - Part 2 - Securing long-term patient options
22 Nov 2021 – From PCR London Valves
Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned, as you can notice in this session broadcast at PCR London Valves 2021 Congress, focusing on this topic area. Watch it now if you wish to understand how key...

Innovation and imaging guidance for tricuspid valve replacement
21 Nov 2021 – From PCR London Valves
Watch this TNT session broadcast at PCR London Valves 2021 Congress to learn more about the crucial importance of understanding imaging and having high-quality imaging to guide transcatheter tricuspid valve intervention.

HighLife TSMVR study status and new developments
22 Nov 2021 – From PCR London Valves 2021
Watch this session from the PCR London Valves 2021 Congress to find out more about HighLife systems and how it works, to witness a live recorded case presentation, to get clinical data, and to get an idea of the upcoming future alterations of the device to...
